CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology
Abstract
CRISPR/Cas technologies have opened new opportunities for the precise genetic engineering of microorganisms relevant to food biotechnology. Their programmability enables targeted genome modification, transcriptional regulation, sequence-specific antimicrobial activity, and nucleic acid detection, offering new strategies to improve fermentation processes, microbial safety, and the functional properties of food-associated strains. However, experimental evidence varies considerably across microorganisms and applications, and successful genome editing does not necessarily translate into improved technological performance. This review examines recent advances in CRISPR/Cas-based engineering of starter cultures, probiotic strains, and production microorganisms, alongside emerging strategies for bacteriophage resistance, pathogen and biofilm control, and food diagnostics. Particular emphasis is placed on distinguishing applications experimentally validated in food-related settings from proof-of-concept studies conducted in laboratory or biomedical contexts. The review also evaluates the major barriers to industrial implementation, including strain-specific editing efficiency, genetic stability, process robustness, and validation in food matrices. It also considers the distinct biosafety and regulatory implications of production microorganisms removed or inactivated during processing versus viable engineered cultures retained in final products. By integrating advances in molecular engineering with evidence of functional performance and practical implementation requirements, this review highlights both the opportunities and current limitations of CRISPR/Cas technologies in food microbial biotechnology.
Related
- Phage-directed precision microbiome medicine: engineering pathobiont depletion, synbiotic succession, microbial-function editing, metabolite host signaling, neurophagomics, and durable ecological state control in gut dysbiosis associated diseases
- CRISPR-Cas9 Editing of Grapevine Clade V-Related MLO Genes: Grapevine Powdery Mildew Resistance (Erysiphe necator) and Plant Development Effects
- Development of a CRISPR-Cas9 genome editing system for the extremely thermophilic bacterium Anaerocellum bescii
- Spatiotemporal Control of Genetic and Epigenetic Editing through Covalent Tethering of CRISPR Nanoparticles to Zwitterionic Microgels
- Auto-SMART: a web-based platform for repair-template design for CRISPR/Cas9 homology-directed editing
BibTeX
@article{juszczukkubiak2026crisprcas,
title = {{CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology}},
author = {Edyta Juszczuk-Kubiak and Natalia Piłka and Ewelina Zielińska and Marek Roszko},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1996037},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1996037},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology
AU - Edyta Juszczuk-Kubiak
AU - Natalia Piłka
AU - Ewelina Zielińska
AU - Marek Roszko
PY - 2026
DA - 2026/10/30
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1996037
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1996037
AB - CRISPR/Cas technologies have opened new opportunities for the precise genetic engineering of microorganisms relevant to food biotechnology. Their programmability enables targeted genome modification, transcriptional regulation, sequence-specific antimicrobial activity, and nucleic acid detection, offering new strategies to improve fermentation processes, microbial safety, and the functional properties of food-associated strains. However, experimental evidence varies considerably across microorganisms and applications, and successful genome editing does not necessarily translate into improved technological performance. This review examines recent advances in CRISPR/Cas-based engineering of starter cultures, probiotic strains, and production microorganisms, alongside emerging strategies for bacteriophage resistance, pathogen and biofilm control, and food diagnostics. Particular emphasis is placed on distinguishing applications experimentally validated in food-related settings from proof-of-concept studies conducted in laboratory or biomedical contexts. The review also evaluates the major barriers to industrial implementation, including strain-specific editing efficiency, genetic stability, process robustness, and validation in food matrices. It also considers the distinct biosafety and regulatory implications of production microorganisms removed or inactivated during processing versus viable engineered cultures retained in final products. By integrating advances in molecular engineering with evidence of functional performance and practical implementation requirements, this review highlights both the opportunities and current limitations of CRISPR/Cas technologies in food microbial biotechnology.
SN - 1664-302X
ER -